Nureca Ltd - 543264 - Related Party Transactions For The Half-Year Ended March 31, 2022
Related Party Transactions for the half-year ended March 31, 202211-06-2022
11-06-2022
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the newspaper publication of the audited financial results for the quarter and financial year ended on March 31, 202230-05-2022
Q4FY22 Quarterly Result Announced for Nureca Ltd.
Healthcare Supplies firm Nureca declares Q4FY22 result: GMV for the FY22 at Rs. 3,403mn as compared to Rs. 2,994mn in FY21, an increase of 14% Operating Revenue was Rs. 2,555mn in FY22 as compared to Rs. 2,135mn in FY21, an increase of 20% Adjusted EBITDA was Rs. 664mn as compared to Rs. 644mn in FY21, an increase of 3% PAT stood at Rs. 450mn as compared to Rs. 464mn in FY21, degrowth of 3% EPS for the FY22 was Rs. 45.0 compared to Rs. 62.0 in FY21. The decline was mainly due to a higher base which is a result of fundraising during the current year. In Q4FY22, We had several one-off costs in terms of professional and legal consultancy fees, setting up of various frameworks and other smaller one-time expenses During the quarter, Aryan Goyal, Founder & CEO of Nureca, was awarded “Top 40 under 40” of the Indian healthcare ecosystem by BW Businessworld Our Employee expenses more than doubled this year as we continue to acquire more talent to expand various business verticals such as Offline entry, Health-tech Platform, entry into Nutraceuticals, baby products, etc. During the quarter we added number new features to our AI driver platform – Dr. Trust 360. This is inline with our strategy of creating a smart home and healthcare ecosystem for our customers. We forayed into the offline market recently and built a strong presence in 22 states and UTs with 120 distributors covering 9000 retail outlets across India. Result PDF30-05-2022
Nureca Ltd - 543264 - Statement Of Deviation And Variation
Statement Of Deviation And Variation29-05-2022
Nureca Ltd - 543264 - Book Closure For The Purpose Of Annual General Meeting
Book Closure for the purpose of Annual General Meeting29-05-2022
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Director29-05-2022
Nureca Ltd - 543264 - Board Meeting Intimation for Notice Of Board Meeting
Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve inter-alia, the audited Financial Results (Standalone and Consolidated) for the fourth quarter and full year ended on March 31, 2022.20-05-2022
Nureca Ltd - 543264 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Secretarial Compliance Report for the year ended March 31, 202229-04-2022